Skip to main content

Table 4 Multivariate analysis of second-line overall survival

From: Efficacy of second-line treatment and prognostic factors in patients with advanced malignant peritoneal mesothelioma: a retrospective study

Covariate

HR (95% CI)

p-value

Age (years), ≥ 63 (vs. <  63)

1.16 (0.41–3.27)

0.78

Cycles of platinum doublet chemotherapy, ≥ 6 (vs. <  6)

0.23 (0.06–0.82)

0.02

Distant metastasis, no (vs. yes)

0.84 (0.30–2.36)

0.74

  1. Abbreviations: CI confidence interval; HR hazard ratio